A new model, which is designed to investigate the in vitro activity of antibiotics as a function of different concentration-time curves, is described. The antibiotic is allowed to diffuse through a membrane into a bacterial culture until a peak level is reached; the antibiotic is then removed by flow-assisted back diffusion. With this arrangement it is possible to expose bacteria to a changing concentration of drug while maintaining a constant volume of bacterial culture. Preliminary studies were carried out to investigate the response of a strain of Escherichia coli to gentamicin. The results indicate that bacteria surviving exposure to concentrations of gentamicin similar to those obtained during therapy may exhibit an increase in resistance to the antibiotic.
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During the treatment of infections, bacteria are exposed to antibacterial agents in a way that differs fundamentally from the conditions of conventional in vitro tests. One of the major differences between the in vitro and in vivo situations is that in vivo the concentration of antibiotic usually increases gradually to reach a peak level and then declines again as the drug is eliminated. To gain a better understanding of the response of bacteria to drugs in these changing circumstances, a model has been constructed in which bacterial cultures may be exposed to concentrations of drug which rise and fall as they do in vivo. In a preliminary evaluation of the model, the response of a strain of Escherichia coli to gentamicin has been investigated. MATERIALS were modified by welding a 25-mm bore-flanged joint to the lower half of the wall, thus providing a lateral opening in each tube. In use, the two tubes were held together with a spring clip, and the space between the tubes was closed by a cellulose acetate membrane (5 cm diameter; 0.45 ,um pore size) held between two silicone rubber gaskets (Fig. 1) . A 10-mm Tefloncoated magnetic stirrer paddle was added to each tube, and the assembly was sterilized by autoclaving.
Use of the model. Forty milliliters of prewarmed (37°C) tris(hydroxymethyl)aminomethane-buffered "complete" medium (5) was added to each tube, and 1 drop of an overnight broth culture of bacteria was added to one side. The assembly was then clamped in place on a magnetic stirrer housed in an incubator. The opacity of the tube containing bacteria was continuously monitored photometrically, using a high-intensity red-light-emitting diode as the light source and a matched phototransistor to collect transmitted light.
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The arrangement of the model in use is shown in Fig.  2 . When bacterial growth commenced, as judged by an increase in the opacity of the culture, gentamicin sulfate (Nicholas Laboratories, Ltd.) was added to the bacteria-free tube and allowed to diffuse into the compartment containing the bacterial culture. To reverse the process of diffusion, broth was pumped into the compartment containing the culture via a syringe needle piercing the rubber bung which sealed the tube.
This created a flow of broth across the membrane into the antibiotic-containing compartment, from which accumulated broth was continuously removed by a second pump. Because of the flow across the membrane, the volume of the bacterial culture remained essentially constant.
Evaluation of the model. The diffusion characteristics of gentamicin in the model were investigated by removing samples at intervals from the culture compartment and assaying the gentamicin concentration, using the well-diffusion method with Klebsiella aerogenes NCTC 10896 as the test organism. In experiments designed to evaluate the use of the model in studying the response of bacteria to gentamicin, a strain of E. coli (laboratory code ECSA 1; a urinary isolate) was used.
Comparison of the susceptibility of bacteria to gentamicin, before and after exposure to the antibiotic in the model, was made by continuous turbidimetric monitoring. Volumes (20-ml) of broth containing graded concentrations of gentamicin were seeded with bacteria from the appropriate cultures to achieve an to the 40 ml of broth on the other side of the membrane (final concentration, 200 ,ug/ml). By varying the amount of gentamicin added, this peak could be increased or decreased. For example, by adding a pulse of 12 mg, a peak of 16. 5 ,ug/ml was achieved after 90 min; by adding a pulse of 4 mg, a peak of 7 jig/ml was achieved.
Instituting a flow rate of 0.3 ml/min into the bacterial compartment immediately reversed the process of diffusion, and the concentration of gentamicin was then progressively reduced to below detectable levels after a further 6 h. If the reverse flow as not initiated, the concentration of drug in the bacterial compartment continued to rise. The profile of drug exposure could therefore be manipulated by varying the amount of gentamicin used or the time at which the reverse flow was begun or both.
The presence of bacterial populations of up to 5 x 106 organisms per ml had little effect on the drug profile achieved in the bacterial compartment of the model, but diffusion was hindered somewhat by bacterial populations exceeding that level, presumably because of blockage of the pores of the membrane. However, the flowassisted back diffusion process was not affected until the opacity of the culture reached a level of about 80% of maximum, i.e., in the prestationary phase, when the viable count was about 5 x 108 bacteria per ml.
The effect of exposing a culture of E. coli to a "dose" of gentamicin was studied. When bacterial growth in the. culture compartment had raised the opacity to a level of 2% of maximum (viable count, about 5 x 106 organisms per ml), sufficient gentamicin to achieve a concentration of 200 ,g/ml was added to the other side of the membrane. After diffusion was allowed to occur for 90 min, the 0.3-ml/min flow of broth was started, reversing the process of diffusion. The profile of exposure to gentamicin achieved by this regimen, estimated by assaying samples from the bacterial compartment at frequent intervals, is shown by the broken line in Fig. 3 .
The response of E. coli to such exposure to gentamicin is also shown in Fig. 3 . As the concentration of gentamicin rose, bacterial growth was halted and the opacity subsequently declined. The reason for this decline was not established, but a similar fall in opacity was observed in dense-inoculum experiments in a static system; therefore, the effect does not appear to be an artifact of the dynamic system. As the antibiotic level again fell to below an inhibitory level, bacterial growth resumed and quickly entered the exponential growth phase.
The susceptibility of this strain of E. coli to gentamicin before and after exposure to the antibiotic in the model, as assessed by continuous turbidimetric monitoring of static cultures exposed to graded concentrations of gentamicin, is shown in Fig. 4 . Before exposure to gentamicin in the model, the minimum antibacterial concentration (the lowest concentration causing an observable antibacterial effect) of the drug was 0.5 ,ug/ml, and the minimum inhibitory concentration (the lowest concentration suppressing growth overnight) was 4 ,ig/ml. Fig. 3 . Tubes of broth containing gentamicin at the concentrations (micrograms per milliliter) shown were inoculated at time zero from the appropriate cultures to achieve an inoculum of about 5 x 105 bacteria per ml.
activity, and one attractive possibility is to construct models which simulate important aspects of the therapeutic situation. One fundamental way in which in vitro tests fail to conform to reality is in the form of exposure of bacteria to antimicrobial drugs: in the body, bacteria are not normally exposed to concentrations of drugs which remain constant. Because in vitro tests are usually conducted in static conditions, little is known of the way in which bacterial populations respond to changing antibiotic concentrations. The present model offers a means of inVestigating this aspect of bacterium-drug interaction.
At the present stage of development, use of the model has been restricted to investigation of aminoglycosides (tobramycin and amikacin, as well as gentamicin, have been successfully used), but extension of the principle to the examination of other antimicrobial drugs should be relatively simple. Manipulation of the experimental conditions to mimic different drug profiles has been shown to be feasible in the present study. It is possible that binding of the antibiotic to the membrane may cause complications in some cases, but examination of the membrane for the presence of residual drug after experiments involving aminoglycosides has not indicated that such a problem exists with this group of antibiotics.
Continuous turbidimetry was chosen as the method for monitoring the response of the bacterial culture. This has notable advantages over the more laborious technique of viable counting in that the test conditions remain undisturbed and a continuous record is obtained over an extended time scale.
Several other attempts have been made to devise systems which simulate in vivo events. One, a model of the urinary bladder (3, 8) , has proved extremely useful in the investigation of bacterial response to drugs in the complex dynamic situation which exists in the infected urinary bladder. More recently, other models have been described which seek to study the effects of changing drug concentrations such as may occur in other treatment situations (2, 6) , but in these systems accumulated drug is removed by dilution, a process which also displaces part of the bacterial culture. The present model overcomes this problem by employing a diffusion technique which leaves the volume of the bacterial culture constant.
In previous experiments in a static system, exposure of E. coli to concentrations of gentamicin lying just below the minimum inhibitory concentration was found to generate a population of bacteria exhibiting increasing aminogly-VOL. 16, 1979 on October 23, 2017 by guest http://aac.asm.org/ coside resistance (5) . Preliminary experiments in the model have attempted to examine whether this phenomenon occurs in the circumstances which exist in vivo, in which the concentration of gentamicin rises transiently above the minimum inhibitory concentration but then falls once more. Such experiments indicate that increased resistance can be induced in these circumstances, but the clinical significance of this phenomenon needs further evaluation. In these preliminary studies a single cycle of drug exposure was employed, whereas in the therapeutic situation continued dosage will reinforce the early antimicrobial effect. Furthermore, in vivo, the drug will usually act in concert with normal host defenses. Nevertheless, these results may help to explain the prevalence of non-enzymeassociated aminoglycoside resistance (9) .
Aminoglycosides have a low therapeutic ratio, and small increments of resistance may compromise the success of therapy. If phagocytosis plays a crucial role in aminoglycoside therapy by countering the tendency for low-level resistant variants to emerge, this may explain the relative ineffectiveness of gentamicin in neutropenic patients (1) .
